MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Clinical trial NCT05090566 · TERMINATED

Trial details

NCT number: NCT05090566
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2021-10-27
Primary completion: 2025-02-13
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.